Pharmaceutical and agricultural company Bayer announced Wednesday its financial projections for the upcoming year. The German corporation expects to generate between $10.4 billion and $11.7 billion in adjusted earnings.

FRANKFURT – The German pharmaceutical and agricultural giant Bayer announced Wednesday its financial outlook for the coming year, projecting adjusted earnings could reach as high as 10.1 billion euros, equivalent to approximately $11.7 billion when currency fluctuations are excluded.
The company released details indicating its 2026 earnings before interest, taxes, depreciation and amortization (EBITDA) before special items are expected to fall within a range of 9.6 billion to 10.1 billion euros, calculated using average 2025 exchange rates.
These projections represent a potential increase from the company’s 2025 performance, when Bayer recorded 9.67 billion euros in similar earnings metrics.
The financial forecast comes as the multinational corporation continues operations in both pharmaceutical development and crop protection products worldwide.
Canadian PM Criticizes US for Not Consulting Allies Before Iran Strikes
Cavaliers Beat Conference-Leading Pistons, Extend Home Win Streak to Seven Games
Japan, US Consider Nuclear Power Deal Worth Up to $100 Billion
Swedish Automaker Volvo Reports 10% Sales Drop Despite Electric Vehicle Growth